Companies - June 4, 2015
Lundbeck Urges Alcohol Curbs
Danish drugmaker Lundbeck, which markets the alcoholism drug Selincro, last month mobilized members of the European Parliament, anti-alcohol NGOs and academics to convince the European Parliament to vote to urge the European Commission to take a harder position against the detrimental affects of alcohol. Lundbeck employees also quietly ran anti-alcohol campaigns behind the scenes, Politico […]
Drug Development Pharma - November 27, 2014
Lundbeck Alcohol Addiction Drug Wins Approval in UK
Just two days after the Danish company’s Lundbeck CEO stepped down for an ethics lapse, the UK’s National Institute for Health and Care Excellence (NICE) gave Selincro (namelfene) approval in final draft guidance, meaning the country’s National Health Service will make funding available for the £42.42-per-14-tablet-pack medication within three months. “We are pleased to be able […]
In a new job - November 25, 2014
Lundbeck CEO Steps Down
Lundbeck CEO Ulf Wiinberg is out of a job after failing to follow procedures on stock ownership. Wiinberg accepted shares of Stratified Medical from its founder last year without permission, violating the company’s internal policies, according to Lundbeck. And it’s an “aggravating circumstance” that Lundbeck later invested about 19 million Danish kronor, equal to US$3.2 […]
